Your browser doesn't support javascript.
Inter-Variability Study of COVLIAS 1.0: Hybrid Deep Learning Models for COVID-19 Lung Segmentation in Computed Tomography.
Suri, Jasjit S; Agarwal, Sushant; Elavarthi, Pranav; Pathak, Rajesh; Ketireddy, Vedmanvitha; Columbu, Marta; Saba, Luca; Gupta, Suneet K; Faa, Gavino; Singh, Inder M; Turk, Monika; Chadha, Paramjit S; Johri, Amer M; Khanna, Narendra N; Viskovic, Klaudija; Mavrogeni, Sophie; Laird, John R; Pareek, Gyan; Miner, Martin; Sobel, David W; Balestrieri, Antonella; Sfikakis, Petros P; Tsoulfas, George; Protogerou, Athanasios; Misra, Durga Prasanna; Agarwal, Vikas; Kitas, George D; Teji, Jagjit S; Al-Maini, Mustafa; Dhanjil, Surinder K; Nicolaides, Andrew; Sharma, Aditya; Rathore, Vijay; Fatemi, Mostafa; Alizad, Azra; Krishnan, Pudukode R; Ferenc, Nagy; Ruzsa, Zoltan; Gupta, Archna; Naidu, Subbaram; Kalra, Mannudeep K.
  • Suri JS; Stroke Diagnostic and Monitoring Division, AtheroPoint™, Roseville, CA 95661, USA.
  • Agarwal S; Advanced Knowledge Engineering Centre, GBTI, Roseville, CA 95661, USA.
  • Elavarthi P; Advanced Knowledge Engineering Centre, GBTI, Roseville, CA 95661, USA.
  • Pathak R; Department of Computer Science Engineering, PSIT, Kanpur 209305, India.
  • Ketireddy V; Advanced Knowledge Engineering Centre, GBTI, Roseville, CA 95661, USA.
  • Columbu M; Thomas Jefferson High School for Science and Technology, Alexandria, VA 22312, USA.
  • Saba L; Department of Computer Science Engineering, Rawatpura Sarkar University, Raipur 492001, India.
  • Gupta SK; Mira Loma High School, Sacramento, CA 95821, USA.
  • Faa G; Department of Radiology, Azienda Ospedaliero Universitaria (A.O.U.), 10015 Cagliari, Italy.
  • Singh IM; Department of Radiology, Azienda Ospedaliero Universitaria (A.O.U.), 10015 Cagliari, Italy.
  • Turk M; Department of Computer Science, Bennett University, Noida 201310, India.
  • Chadha PS; Department of Pathology, Azienda Ospedaliero Universitaria (A.O.U.), 10015 Cagliari, Italy.
  • Johri AM; Stroke Diagnostic and Monitoring Division, AtheroPoint™, Roseville, CA 95661, USA.
  • Khanna NN; The Hanse-Wissenschaftskolleg Institute for Advanced Study, 27753 Delmenhorst, Germany.
  • Viskovic K; Stroke Diagnostic and Monitoring Division, AtheroPoint™, Roseville, CA 95661, USA.
  • Mavrogeni S; Department of Medicine, Division of Cardiology, Queen's University, Kingston, ON K7L 3N6, Canada.
  • Laird JR; Department of Cardiology, Indraprastha APOLLO Hospitals, New Delhi 110076, India.
  • Pareek G; University Hospital for Infectious Diseases, 10000 Zagreb, Croatia.
  • Miner M; Cardiology Clinic, Onassis Cardiac Surgery Center, 10558 Athens, Greece.
  • Sobel DW; Heart and Vascular Institute, Adventist Health St. Helena, St. Helena, CA 94574, USA.
  • Balestrieri A; Minimally Invasive Urology Institute, Brown University, Providence, RI 02912, USA.
  • Sfikakis PP; Men's Health Center, Miriam Hospital, Providence, RI 02906, USA.
  • Tsoulfas G; Minimally Invasive Urology Institute, Brown University, Providence, RI 02912, USA.
  • Protogerou A; Department of Radiology, Azienda Ospedaliero Universitaria (A.O.U.), 10015 Cagliari, Italy.
  • Misra DP; Rheumatology Unit, National & Kapodistrian University of Athens, 10679 Athens, Greece.
  • Agarwal V; Aristoteleion University of Thessaloniki, 54636 Thessaloniki, Greece.
  • Kitas GD; National & Kapodistrian University of Athens, 10679 Athens, Greece.
  • Teji JS; Department of Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226014, India.
  • Al-Maini M; Department of Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226014, India.
  • Dhanjil SK; Academic Affairs, Dudley Group NHS Foundation Trust, Dudley DY1 2HQ, UK.
  • Nicolaides A; Arthritis Research UK Epidemiology Unit, Manchester University, Manchester M13 9PT, UK.
  • Sharma A; Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL 60611, USA.
  • Rathore V; Allergy, Clinical Immunology and Rheumatology Institute, Toronto, ON L4Z 4C4, Canada.
  • Fatemi M; AtheroPoint LLC, Roseville, CA 95611, USA.
  • Alizad A; Vascular Screening and Diagnostic Centre, University of Nicosia Medical School, Nicosia 2368, Cyprus.
  • Krishnan PR; Division of Cardiovascular Medicine, University of Virginia, Charlottesville, VA 22904, USA.
  • Ferenc N; AtheroPoint LLC, Roseville, CA 95611, USA.
  • Ruzsa Z; Department of Physiology & Biomedical Engineering, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA.
  • Gupta A; Department of Radiology, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA.
  • Naidu S; Neurology Department, Fortis Hospital, Bangalore 560076, India.
  • Kalra MK; Internal Medicine Department, University of Szeged, 6725 Szeged, Hungary.
Diagnostics (Basel) ; 11(11)2021 Nov 01.
Article in English | MEDLINE | ID: covidwho-1488513
ABSTRACT

Background:

For COVID-19 lung severity, segmentation of lungs on computed tomography (CT) is the first crucial step. Current deep learning (DL)-based Artificial Intelligence (AI) models have a bias in the training stage of segmentation because only one set of ground truth (GT) annotations are evaluated. We propose a robust and stable inter-variability analysis of CT lung segmentation in COVID-19 to avoid the effect of bias.

Methodology:

The proposed inter-variability study consists of two GT tracers for lung segmentation on chest CT. Three AI models, PSP Net, VGG-SegNet, and ResNet-SegNet, were trained using GT annotations. We hypothesized that if AI models are trained on the GT tracings from multiple experience levels, and if the AI performance on the test data between these AI models is within the 5% range, one can consider such an AI model robust and unbiased. The K5 protocol (training to testing 80%20%) was adapted. Ten kinds of metrics were used for performance evaluation.

Results:

The database consisted of 5000 CT chest images from 72 COVID-19-infected patients. By computing the coefficient of correlations (CC) between the output of the two AI models trained corresponding to the two GT tracers, computing their differences in their CC, and repeating the process for all three AI-models, we show the differences as 0%, 0.51%, and 2.04% (all < 5%), thereby validating the hypothesis. The performance was comparable; however, it had the following order ResNet-SegNet > PSP Net > VGG-SegNet.

Conclusions:

The AI models were clinically robust and stable during the inter-variability analysis on the CT lung segmentation on COVID-19 patients.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Prognostic study Language: English Year: 2021 Document Type: Article Affiliation country: Diagnostics11112025

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Prognostic study Language: English Year: 2021 Document Type: Article Affiliation country: Diagnostics11112025